Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer

Background: Immune checkpoint inhibitors (ICIs) have changed the treatment paradigm of advanced-stage non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). The aim of this study was to evaluate the effectiveness and tolerance of ICIs in a real-world patient population and to investig...

Full description

Bibliographic Details
Main Authors: Shijia Zhang, Daniel F Pease, Amit A Kulkarni, Manoj Kumar, Ryan M Shanley, Beibei Xu, Shilvi P Joshi, Manish R Patel
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/11795549211004489

Similar Items

Similar Items